EUVIMEDEUVIMED entdecken
Crossref

A highly sensitive first derivative synchronous spectrofluorimetric approach for the simultaneous analysis of the anti-breast cancer co-administered drugs, letrozole and tramadol in dosage forms and human plasma at nanogram levels

Aya Saad Radwan, Mohamed A El Hamd, Mahmoud El-Maghrabey, Fotouh R Mansour, Wael A Mahdi, Sultan Alshehri, Bandar R Alsehli, Galal Magdy

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2024-10 · 319 · 124532

DOI: 10.1016/j.saa.2024.124532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2024-10. Verfasst von Aya Saad Radwan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt. Electronic address: ayasradwan93@gmail.com. Hauptthemen laut MEDLINE: Letrozole, Tramadol, Spectrometry, Fluorescence, Breast Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Shaqra University, King Saud University, King Saud University Deanship of Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Letrozole is an anticancer medication prescribed for the management of estrogen receptor-positive breast cancer in postmenopausal women. Chronic pain is prevalent in patients receiving chemotherapy, leading to the use of adjuvant analgesics such as tramadol. This work introduces the first analytical approach for the concurrent quantification of letrozole and tramadol, two co-administered drugs, employing a rapid, highly sensitive, eco-friendly, and cost-effective first derivative synchronous spectrofluorimetric technique. The fluorescence of tramadol and letrozole was measured at wavelengths of 235.9 nm and 241.9 nm, respectively using a wavelength difference (Δλ) of 60.0 nm. The developed approach demonstrated exceptional linearity (r ˃ 0.999) within the specified concentration ranges for tramadol (10.0-1200.0 ng/mL) and letrozole (1.0-140.0 ng/mL). The results demonstrated that the proposed technique exhibits a high level of sensitivity, with detection limits of 0.569 and 0.143 ng/mL for tramadol and letrozole, respectively, indicating the good bioanalytical applicability. The within-run precisions, both intra-day and inter-day, for both analytes, were less than 0.71 % RSD. The developed approach was effectively applied to simultaneously estimate the mentioned drugs in their tablets and human plasma samples, achieving high percentage recoveries and low % RSD values. In order to assess the environmental sustainability of the developed approach, Analytical GREEnnessNNESS (AGREE) and the Green Analytical Procedure Index (GAPI) metric tools were employed. Both tools revealed that the developed approach is excellent green, suggesting its usage as an environmentally-friendly alternative for the routine assayof the investigated pharmaceuticals. The developed approach was validated according to the ICHQ2 (R1) requirements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LetrozoleTramadolSpectrometry, FluorescenceBreast NeoplasmsLimit of DetectionHumansFemaleAntineoplastic AgentsReproducibility of ResultsTablets

Stichwörter der Autor:innen

AnticancerGreennessLetrozolePlasmaSynchronous spectrofluorimetryTramadol

Substanzen

LetrozoleTramadolAntineoplastic AgentsTablets

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt. Electronic address: ayasradwan93@gmail.com.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena 83523, Eg…
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: dr_m_hamed@mans.edu.eg.
  • Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.

Förderung

  • Shaqra University
  • King Saud University
  • King Saud University Deanship of Scientific Research

Zitieren

APA

Radwan, A. S., El Hamd, M. A., El-Maghrabey, M., Mansour, F. R., Mahdi, W. A., Alshehri, S., Alsehli, B. R., & Magdy, G. (2024). A highly sensitive first derivative synchronous spectrofluorimetric approach for the simultaneous analysis of the anti-breast cancer co-administered drugs, letrozole and tramadol in dosage forms and human plasma at nanogram levels. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 319, 124532. https://doi.org/10.1016/j.saa.2024.124532

Vancouver

Radwan AS, El Hamd MA, El-Maghrabey M, Mansour FR, Mahdi WA, Alshehri S, et al. A highly sensitive first derivative synchronous spectrofluorimetric approach for the simultaneous analysis of the anti-breast cancer co-administered drugs, letrozole and tramadol in dosage forms and human plasma at nanogram levels. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2024;319:124532. doi:10.1016/j.saa.2024.124532

BibTeX
@article{Radwan2024,
  author = {Radwan, Aya Saad and El Hamd, Mohamed A and El-Maghrabey, Mahmoud and Mansour, Fotouh R and Mahdi, Wael A and Alshehri, Sultan and Alsehli, Bandar R and Magdy, Galal},
  title = {A highly sensitive first derivative synchronous spectrofluorimetric approach for the simultaneous analysis of the anti-breast cancer co-administered drugs, letrozole and tramadol in dosage forms and human plasma at nanogram levels},
  journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
  year = {2024},
  volume = {319},
  pages = {124532},
  doi = {10.1016/j.saa.2024.124532}
}
Kostenlos starten →